Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

The document covers various dermatological conditions and their studies.

The document explains various skin conditions and their treatments.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The patient has frontal fibrosing alopecia (FFA).

Red dots on the upper chest may be an early sign of certain types of hair loss.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some women with common hair loss may develop permanent hair loss.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.